Clene Nanomedicine, Inc. is an innovative clinical-stage biopharmaceutical company based in Salt Lake City, Utah. It is focused on the development of potentially first-in-class nanocatalysts for the treatment of bioenergetic failure associated with neurodegenerative diseases.